Biophysical Analysis of GPIb-VWF Interaction
GPIb-VWF 相互作用的生物物理分析
基本信息
- 批准号:8024484
- 负责人:
- 金额:$ 36.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsBindingBlood CirculationBlood PlateletsBlood VesselsBlood flowCollagenDataDiseaseEnvironmentExtracellular MatrixGlycoprotein IbHemorrhageHemostatic functionInjuryInterventionKineticsMechanicsMediatingMolecularMolecular StructureMutationNamesPathologyPatientsPhysiologyPlasma ProteinsPlatelet GlycoproteinsPrincipal InvestigatorPropertyProteinsRegulationResearchSignal TransductionSiteSurfaceTestingThrombosisVariantadhesion processinsightmolecular dynamicsnovel therapeutic interventionprogramsvon Willebrand Diseasevon Willebrand Factor
项目摘要
DESCRIPTION (provided by applicant): The objective of this proposal is to elucidate the molecular and biophysical mechanisms that regulate platelet adhesion to disrupted vessel wall at sites of injury. The focus is the interaction of the platelet glycoprotein Ib (GPIb) with plasma protein von Willebrand factor (VWF) that is bound to collagen on subendothelial extracellular matrix. The GPIb-VWF interaction mediates the initial step of the multistep adhesion and signaling cascade, which includes platelet tethering to and rolling (or translocating) on disrupted vascular surfaces. Regulation of this initial adhesion process is crucial: Insufficient adhesion cannot stop bleeding to maintain hemostasis. Excessive adhesion results in thrombosis. Our hypothesis is that initial platelet adhesion is regulated by the interplay of biophysical parameters of the blood flow with specific kinetic and mechanical properties of the GPIb-VWF interaction. Mutations in GPIb and VWF, such as those naturally occurring in patients with various types of von Willebrand diseases (VWD), alter these kinetic and mechanical properties as well as their regulation by biophysical parameters, thereby changing platelet adhesion and resulting in thrombotic or bleeding disorders. Using combined experimental, computational, and theoretical approaches, this hypothesis will be tested in three integrated specific aims: 1) Quantify the regulation of GPIb-VWF interaction by biophysical parameters, 2) Determine the regulation of GPIb-VWF interaction by structural variations, and 3) Investigate GPIb-VWF interaction by molecular dynamics simulations. This integrated and systematic study will clarify how the kinetic and mechanical properties of GPIb-VWF interaction fulfill the biophysical requirements for platelets to adhere to blood vessel wall in the mechanically stressful environment of the circulation. Decoding how molecular structure determines these properties and their regulation by biophysical parameters will provide key insights into vascular physiology and pathology. As a result, the data may offer new therapeutic approaches to inhibiting pathological platelet adhesion during thrombosis and/or intervention to the bleeding disorder.
We propose to elucidate the biophysical mechanisms that regulate the molecular interaction of the platelet glycoprotein Ib (GPIb) with protein von Willebrand factor, which mediates platelet adhesion to disrupted vessel wall at sites of injury. This regulation is crucial because insufficient adhesion cannot stop bleeding to maintain hemostasis but excessive adhesion results in thrombosis. The data may offer new therapeutic approaches to inhibiting pathological platelet adhesion during thrombosis and/or intervention to the bleeding disorder von Willebrand diseases.
描述(由申请人提供):本提案的目的是阐明调节血小板粘附至损伤部位破裂血管壁的分子和生物物理机制。重点是血小板糖蛋白Ib(GPIb)与血浆蛋白血管性血友病因子(VWF)的相互作用,该因子与内皮下细胞外基质上的胶原蛋白结合。GPIb-VWF相互作用介导了多步粘附和信号级联的初始步骤,其包括血小板在破裂的血管表面上束缚和滚动(或移位)。调节这种初始粘附过程至关重要:粘附不足无法止血以维持止血。过度粘连导致血栓形成。我们的假设是,初始血小板粘附调节的生物物理参数的血流与特定的动力学和机械性能的GPIb-VWF相互作用的相互作用。GPIb和VWF中的突变,例如在患有各种类型的血管性血友病(VWD)的患者中天然存在的那些突变,改变这些动力学和机械性质以及它们通过生物物理参数的调节,从而改变血小板粘附并导致血栓形成或出血性疾病。结合实验,计算和理论方法,这一假设将在三个综合的具体目标进行测试:1)量化的GPIb-VWF相互作用的生物物理参数的调节,2)确定GPIb-VWF相互作用的结构变化的调节,和3)研究GPIb-VWF相互作用的分子动力学模拟。这项综合和系统的研究将阐明GPIb-VWF相互作用的动力学和机械性质如何满足血小板在循环的机械压力环境中粘附于血管壁的生物物理要求。解码分子结构如何决定这些特性及其通过生物物理参数的调节将为血管生理学和病理学提供关键见解。因此,这些数据可能提供新的治疗方法来抑制血栓形成期间的病理性血小板粘附和/或对出血性疾病的干预。
我们建议阐明调节血小板糖蛋白Ib(GPIb)与血管性血友病因子(vonWillebrand factor)的分子相互作用的生物物理机制,该因子介导血小板粘附到损伤部位的破裂血管壁。这种调节至关重要,因为粘附不足无法止血以维持止血,但粘附过度会导致血栓形成。这些数据可能提供新的治疗方法,以抑制血栓形成过程中的病理性血小板粘附和/或干预出血性疾病血管性血友病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheng Zhu其他文献
Cheng Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cheng Zhu', 18)}}的其他基金
Mechanotransduction of platelet receptors GPIb and GPIIb-IIIa
血小板受体 GPIb 和 GPIIb-IIIa 的机械转导
- 批准号:
10458027 - 财政年份:2016
- 资助金额:
$ 36.82万 - 项目类别:
Mechanotransduction of platelet receptors GPIb and GPIIb-IIIa
血小板受体 GPIb 和 GPIIb-IIIa 的机械转导
- 批准号:
10670136 - 财政年份:2016
- 资助金额:
$ 36.82万 - 项目类别:
Mechanotransduction of platelet receptors GPIb and GPIIb-IIIa
血小板受体 GPIb 和 GPIIb-IIIa 的机械转导
- 批准号:
10298451 - 财政年份:2016
- 资助金额:
$ 36.82万 - 项目类别:
Structural bases of ADAMTS-13 and VWF A2 interactions
ADAMTS-13 和 VWF A2 相互作用的结构基础
- 批准号:
8019207 - 财政年份:2011
- 资助金额:
$ 36.82万 - 项目类别:
Structural bases of ADAMTS-13 and VWF A2 interactions
ADAMTS-13 和 VWF A2 相互作用的结构基础
- 批准号:
8410081 - 财政年份:2011
- 资助金额:
$ 36.82万 - 项目类别:
Structural bases of ADAMTS-13 and VWF A2 interactions
ADAMTS-13 和 VWF A2 相互作用的结构基础
- 批准号:
8209109 - 财政年份:2011
- 资助金额:
$ 36.82万 - 项目类别:
STRUCTURAL MECHANISM OF INTEGRIN ACTIVATIN INDUCED BY TALIN
TALIN诱导整合素激活素的结构机制
- 批准号:
8364189 - 财政年份:2011
- 资助金额:
$ 36.82万 - 项目类别:
MOLECULAR SIMULATIONS OF INTEGRIN CONFORMATIONAL CHANGE
整合素构象变化的分子模拟
- 批准号:
7956229 - 财政年份:2009
- 资助金额:
$ 36.82万 - 项目类别:
Mechanical Regulation of Binding and Cleavage of VWF by ADAMTS-13
ADAMTS-13 对 VWF 结合和裂解的机械调节
- 批准号:
7663571 - 财政年份:2009
- 资助金额:
$ 36.82万 - 项目类别:
Mechanical Regulation of Binding and Cleavage of VWF by ADAMTS-13
ADAMTS-13 对 VWF 结合和裂解的机械调节
- 批准号:
8274715 - 财政年份:2009
- 资助金额:
$ 36.82万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 36.82万 - 项目类别:
Discovery Projects














{{item.name}}会员




